β¨ Health Appointments and Medicine Notices
32 NEW ZEALAND GAZETTE, No. 1 13 JANUARY 2011
Dr David Galler
Dr Peter Jansen
Geraint Martin
Anthea Penny
as members of the Health Quality and Safety Commission board.
These appointments commence on 1 December 2010 and end on 30 November 2013.
Dated at Wellington this 26th day of November 2010.
HON TONY RYALL, Minister of Health.
go31
Health Act 1956
Appointments to the National Cervical Screening Programme Review Committee
Pursuant to section 112O of the Health Act 1956, I appoint to the National Cervical Screening Programme Review Committee
Dr Jeffrey Tan
as chair for a six-month term of office commencing on the date of this notification; and
Dr Roberta (Robbi) Howlett
Linda Thompson
as members for six-month terms of office commencing on the date of this notification.
Dated at Wellington this 10th day of January 2011.
HON TARIANA TURIA, Associate Minister of Health.
go183
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Utrogestan
Active Ingredient: Progesterone 100mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: Capsugel, Zone Industrielle de Camagnon, Ploermel, France
Note: This renewed consent is valid for two years from 2 April 2011.
Dated this 10th day of January 2011.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go189
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Panvax vaccine
Active Ingredient: Influenza Virus Type A haemagglutinin 30ΞΌg
Dosage Form: Suspension for injection
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: CSL Limited, Parkville, Australia
Note: This consent is given subject to the following conditions:
- The vaccine may only be marketed, distributed or supplied in accordance with the directives contained in the New Zealand National Health Emergency Plan: New Zealand Influenza Pandemic Action Plan.
- In an official declared influenza pandemic situation, CSL is to provide updated evidence of the surrogate markers used to estimate efficacy of the pandemic vaccine formulation and is committed to provide PSURs as outlined in the Risk Management Plan.
Also Note: This consent is valid for two years from the date of publication of this notice.
Dated this 10th day of January 2011.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go188
Next Page →
β¨ LLM interpretation of page content
π₯
Appointments to the Health Quality and Safety Commission
(continued from previous page)
π₯ Health & Social Welfare26 November 2010
Health Quality and Safety Commission, Appointments, Board Members
- David Galler (Dr), Appointed member of the Health Quality and Safety Commission board
- Peter Jansen (Dr), Appointed member of the Health Quality and Safety Commission board
- Geraint Martin, Appointed member of the Health Quality and Safety Commission board
- Anthea Penny, Appointed member of the Health Quality and Safety Commission board
- HON TONY RYALL, Minister of Health
π₯ Appointments to the National Cervical Screening Programme Review Committee
π₯ Health & Social Welfare10 January 2011
National Cervical Screening Programme, Review Committee, Appointments
- Jeffrey Tan (Dr), Appointed chair of the National Cervical Screening Programme Review Committee
- Roberta (Robbi) Howlett (Dr), Appointed member of the National Cervical Screening Programme Review Committee
- Linda Thompson, Appointed member of the National Cervical Screening Programme Review Committee
- HON TARIANA TURIA, Associate Minister of Health
π₯ Renewal of Provisional Consent to the Distribution of a Medicine
π₯ Health & Social Welfare10 January 2011
Medicines Act 1981, Provisional Consent, Utrogestan, Progesterone
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare10 January 2011
Medicines Act 1981, Provisional Consent, Panvax vaccine, Influenza
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
NZ Gazette 2011, No 1